Overview of the network
The main aim of the national clinical research network for ALS, the Alliance on Clinical Trials for Amyotrophic Lateral Sclerosis - Motor Neurone Disease (ACT4ALS-MND), is to pool the expertise of French ALS centres and take advantage of the very large group of patients currently being monitored, to develop therapeutic trials and national or joint European and international clinical studies.
The ACT4ALS-MND network has been up and running since the summer of 2020, and a number of projects are being developed through it.
2022
ACT4ALS-MND receives F-CRIN accreditation !
22
French ALS centers member of the network
Reference centers certified by DGOS (Directorate of Health Care Supply)
Map of the network members
Here is a map of the ALS/MND centers in the ACT4ALS-MND network participating in clinical trials in France






